Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion
10.1007/s00401-012-1048-7
Crossref journal-article
Springer Science and Business Media LLC
Acta Neuropathologica (297)
Bibliography

Bieniek, K. F., Murray, M. E., Rutherford, N. J., Castanedes-Casey, M., DeJesus-Hernandez, M., Liesinger, A. M., Baker, M. C., Boylan, K. B., Rademakers, R., & Dickson, D. W. (2012). Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion. Acta Neuropathologica, 125(2), 289–302.

Authors 10
  1. Kevin F. Bieniek (first)
  2. Melissa E. Murray (additional)
  3. Nicola J. Rutherford (additional)
  4. Monica Castanedes-Casey (additional)
  5. Mariely DeJesus-Hernandez (additional)
  6. Amanda M. Liesinger (additional)
  7. Matthew C. Baker (additional)
  8. Kevin B. Boylan (additional)
  9. Rosa Rademakers (additional)
  10. Dennis W. Dickson (additional)
References 53 Referenced 87
  1. Al-Sarraj S, King A, Troakes C et al (2011) p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol 122:691–702 (10.1007/s00401-011-0911-2) / Acta Neuropathol by S Al-Sarraj (2011)
  2. Amador-Ortiz C, Lin WL, Ahmed Z et al (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 61:435–445 (10.1002/ana.21154) / Ann Neurol by C Amador-Ortiz (2007)
  3. Arai T, Mackenzie IR, Hasegawa M et al (2009) Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies. Acta Neuropathol 117:125–136 (10.1007/s00401-008-0480-1) / Acta Neuropathol by T Arai (2009)
  4. Babu JR, Geetha T, Wooten MW (2005) Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J Neurochem 94:192–203 (10.1111/j.1471-4159.2005.03181.x) / J Neurochem by JR Babu (2005)
  5. Behrens MI, Mukherjee O, Tu PH et al (2007) Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation. Alzheimer Dis Assoc Disord 21:1–7 (10.1097/WAD.0b013e31803083f2) / Alzheimer Dis Assoc Disord by MI Behrens (2007)
  6. Boeve BF, Boylan KB, Graff-Radford NR et al (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135:765–783 (10.1093/brain/aws004) / Brain by BF Boeve (2012)
  7. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239–259 (10.1007/BF00308809) / Acta Neuropathol by H Braak (1991)
  8. Brettschneider J, Van Deerlin VM, Robinson JL et al (2012) Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathol 123:825–839 (10.1007/s00401-012-0970-z) / Acta Neuropathol by J Brettschneider (2012)
  9. Cairns NJ, Bigio EH, Mackenzie IR et al (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5–22 (10.1007/s00401-007-0237-2) / Acta Neuropathol by NJ Cairns (2007)
  10. Dai RM, Li CC (2001) Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat Cell Biol 3:740–744 (10.1038/35087056) / Nat Cell Biol by RM Dai (2001)
  11. DeJesus-Hernandez M, Mackenzie IR, Boeve BF et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245–256 (10.1016/j.neuron.2011.09.011) / Neuron by M DeJesus-Hernandez (2011)
  12. Deng HX, Chen WJ, Hong ST et al (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477:211–215 (10.1038/nature10353)
  13. Dickson DW, Crystal HA, Mattiace LA et al (1992) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 13:179–189 (10.1016/0197-4580(92)90027-U) / Neurobiol Aging by DW Dickson (1992)
  14. Dickson DW, Wertkin A, Kress Y, Ksiezak-Reding H, Yen SH (1990) Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab Invest 63:87–99 / Lab Invest by DW Dickson (1990)
  15. Forman MS, Mackenzie IR, Cairns NJ et al (2006) Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol 65:571–581 (10.1097/00005072-200606000-00005) / J Neuropathol Exp Neurol by MS Forman (2006)
  16. Gass J, Cannon A, Mackenzie IR et al (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 15:2988–3001 (10.1093/hmg/ddl241) / Hum Mol Genet by J Gass (2006)
  17. Graff-Radford NR, Woodruff BK (2007) Frontotemporal dementia. Semin Neurol 27:48–57 (10.1055/s-2006-956755) / Semin Neurol by NR Graff-Radford (2007)
  18. Hiltunen M, Lu A, Thomas AV et al (2006) Ubiquilin 1 modulates amyloid precursor protein trafficking and Abeta secretion. J Biol Chem 281:32240–32253 (10.1074/jbc.M603106200) / J Biol Chem by M Hiltunen (2006)
  19. Hsiung GYR, DeJesus-Hernandez M, Feldman HH et al (2012) Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain 135:709–722 (10.1093/brain/awr354) / Brain by GYR Hsiung (2012)
  20. Hu WT, Josephs KA, Knopman DS et al (2008) Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol 116:215–220 (10.1007/s00401-008-0400-4) / Acta Neuropathol by WT Hu (2008)
  21. Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095–1097 (10.1097/00005072-199710000-00002) / J Neuropathol Exp Neurol by BT Hyman (1997)
  22. Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:427–436 (10.1007/s00401-008-0347-5) / Acta Neuropathol by KA Jellinger (2008)
  23. Josephs KA, Stroh A, Dugger B, Dickson DW (2009) Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol 118:349–358 (10.1007/s00401-009-0547-7) / Acta Neuropathol by KA Josephs (2009)
  24. Josephs KA, Tsuboi Y, Cookson N, Watt H, Dickson DW (2004) Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. Arch Neurol 61:1579–1584 (10.1001/archneur.61.10.1579) / Arch Neurol by KA Josephs (2004)
  25. Josephs KA, Whitwell JL, Knopman DS et al (2008) Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70:1850–1857 (10.1212/01.wnl.0000304041.09418.b1) / Neurology by KA Josephs (2008)
  26. Kelley BJ, Haidar W, Boeve BF et al (2009) Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging 30:739–751 (10.1016/j.neurobiolaging.2007.08.022) / Neurobiol Aging by BJ Kelley (2009)
  27. Khachaturian ZS (1985) Diagnosis of Alzheimer’s disease. Arch Neurol 42:1097–1105 (10.1001/archneur.1985.04060100083029) / Arch Neurol by ZS Khachaturian (1985)
  28. Kuusisto E, Salminen A, Alafuzoff I (2001) Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies. NeuroReport 12:2085–2090 (10.1097/00001756-200107200-00009) / NeuroReport by E Kuusisto (2001)
  29. Kuusisto E, Salminen A, Alafuzoff I (2002) Early accumulation of p62 in neurofibrillary tangles in Alzheimer’s disease: possible role in tangle formation. Neuropathol Appl Neurobiol 28:228–237 (10.1046/j.1365-2990.2002.00394.x) / Neuropathol Appl Neurobiol by E Kuusisto (2002)
  30. Lendon CL, Lynch T, Norton J et al (1998) Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22. Neurology 50:1546–1555 (10.1212/WNL.50.6.1546) / Neurology by CL Lendon (1998)
  31. Lomen-Hoerth C, Anderson T, Miller B (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59:1077–1079 (10.1212/WNL.59.7.1077) / Neurology by C Lomen-Hoerth (2002)
  32. Lomen-Hoerth C, Murphy J, Langmore S et al (2003) Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60:1094–1097 (10.1212/01.WNL.0000055861.95202.8D) / Neurology by C Lomen-Hoerth (2003)
  33. Mackenzie IRA, Baborie A, Pickering-Brown S et al (2006) Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol 112:539–549 (10.1007/s00401-006-0138-9) / Acta Neuropathol by IRA Mackenzie (2006)
  34. Mackenzie IRA, Neumann M, Baborie A et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111–113 (10.1007/s00401-011-0845-8) / Acta Neuropathol by IRA Mackenzie (2011)
  35. Mah AL, Perry G, Smith MA, Monteiro MJ (2000) Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J Cell Biol 151:847–862 (10.1083/jcb.151.4.847) / J Cell Biol by AL Mah (2000)
  36. Mahoney CJ, Beck J, Rohrer JD et al (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 135:736–750 (10.1093/brain/awr361) / Brain by CJ Mahoney (2012)
  37. Murray ME, DeJesus-Hernandez M, Rutherford NJ et al (2011) Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol 122:673–690 (10.1007/s00401-011-0907-y) / Acta Neuropathol by ME Murray (2011)
  38. Murray ME, Graff-Radford NR, Ross OA et al (2011) Neuropathologically defined subtypes of Alzheimer’s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785–796 (10.1016/S1474-4422(11)70156-9) / Lancet Neurol by ME Murray (2011)
  39. Neumann M, Rademakers R, Roeber S et al (2009) A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132:2922–2931 (10.1093/brain/awp214) / Brain by M Neumann (2009)
  40. Parkinson N, Ince PG, Smith MO et al (2006) ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67:1074–1077 (10.1212/01.wnl.0000231510.89311.8b) / Neurology by N Parkinson (2006)
  41. Rademakers R, Baker M, Gass J et al (2007) Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C → T (Arg493X) mutation: an international initiative. Lancet Neurol 6:857–868 (10.1016/S1474-4422(07)70221-1) / Lancet Neurol by R Rademakers (2007)
  42. Renton AE, Majounie E, Waite A et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257–268 (10.1016/j.neuron.2011.09.010) / Neuron by AE Renton (2011)
  43. Ringholz GM, Appel SH, Bradshaw M et al (2005) Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65:586–590 (10.1212/01.wnl.0000172911.39167.b6) / Neurology by GM Ringholz (2005)
  44. Rutherford NJ, Zhang YJ, Baker M et al (2008) Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet 4:e1000193 (10.1371/journal.pgen.1000193) / PLoS Genet by NJ Rutherford (2008)
  45. Simon-Sanchez J, Dopper EGP, Cohn-Hokke PE et al (2012) The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain 135:723–735 (10.1093/brain/awr353) / Brain by J Simon-Sanchez (2012)
  46. Stieren ES, El Ayadi A, Xiao Y et al (2011) Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein. J Biol Chem 286:35689–35698 (10.1074/jbc.M111.243147) / J Biol Chem by ES Stieren (2011)
  47. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800 (10.1212/WNL.58.12.1791) / Neurology by DR Thal (2002)
  48. Togo T, Cookson N, Dickson DW (2002) Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 12:45–52 (10.1111/j.1750-3639.2002.tb00421.x) / Brain Pathol by T Togo (2002)
  49. Troakes C, Maekawa S, Wijesekera L et al (2011) An MND/ALS phenotype associated with C9orf72 repeat expansion: Abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline. Neuropathology 32:505–514 (10.1111/j.1440-1789.2011.01286.x)
  50. Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685–697 (10.1097/01.jnen.0000225908.90052.07) / J Neuropathol Exp Neurol by H Uchikado (2006)
  51. Uryu K, Nakashima-Yasuda H, Forman MS et al (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555–564 (10.1097/NEN.0b013e31817713b5) / J Neuropathol Exp Neurol by K Uryu (2008)
  52. van Harten AC, Kester MI, Visser PJ et al (2011) Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med 49:353–366 (10.1515/CCLM.2011.086) / Clin Chem Lab Med by AC Harten van (2011)
  53. Watts GDJ, Wymer J, Kovach MJ et al (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377–381 (10.1038/ng1332) / Nat Genet by GDJ Watts (2004)
Dates
Type When
Created 12 years, 10 months ago (Sept. 27, 2012, 8:10 p.m.)
Deposited 6 years, 2 months ago (May 28, 2019, 1:24 p.m.)
Indexed 2 months, 4 weeks ago (May 26, 2025, 1:27 p.m.)
Issued 12 years, 10 months ago (Sept. 28, 2012)
Published 12 years, 10 months ago (Sept. 28, 2012)
Published Online 12 years, 10 months ago (Sept. 28, 2012)
Published Print 12 years, 6 months ago (Feb. 1, 2013)
Funders 0

None

@article{Bieniek_2012, title={Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion}, volume={125}, ISSN={1432-0533}, url={http://dx.doi.org/10.1007/s00401-012-1048-7}, DOI={10.1007/s00401-012-1048-7}, number={2}, journal={Acta Neuropathologica}, publisher={Springer Science and Business Media LLC}, author={Bieniek, Kevin F. and Murray, Melissa E. and Rutherford, Nicola J. and Castanedes-Casey, Monica and DeJesus-Hernandez, Mariely and Liesinger, Amanda M. and Baker, Matthew C. and Boylan, Kevin B. and Rademakers, Rosa and Dickson, Dennis W.}, year={2012}, month=sep, pages={289–302} }